Ruxolitinib improves outcomes in association with altered fibroblast immunobiology in mouse models of Sjögren's disease.

Adam RJ, Gurevic I, Yamada E, Vande Loo A, Zhou FP, McCoy SS

DOI: 10.1093/rheumatology/keag619
Published: 2026 Nov 10
Container: Rheumatology (Oxford, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag619,
  title = {Ruxolitinib improves outcomes in association with altered fibroblast immunobiology in mouse models of Sjögren's disease.},
  author = {Adam RJ and Gurevic I and Yamada E and Vande Loo A and Zhou FP and McCoy SS},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag619},
  url = {https://doi.org/10.1093/rheumatology/keag619}
}

RIS

TY  - JOUR
TI  - Ruxolitinib improves outcomes in association with altered fibroblast immunobiology in mouse models of Sjögren's disease.
AU  - Adam RJ
AU  - Gurevic I
AU  - Yamada E
AU  - Vande Loo A
AU  - Zhou FP
AU  - McCoy SS
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag619
UR  - https://doi.org/10.1093/rheumatology/keag619
ER  -

APA

RJ, A., I, G., E, Y., A, V. L., FP, Z., & SS, M. (2026). Ruxolitinib improves outcomes in association with altered fibroblast immunobiology in mouse models of Sjögren's disease.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag619

Source records

pubmed · retrieved 2026-11-10T19:05:56.581Z